Comment on Biotech firm backs off its focus on oncology research

Biotech firm backs off its focus on oncology research

By abandoning oncology research, IGM reduced its year-over-year R&D expenses to $46.1 million from $54.8 million.

 

Comment On This Story

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News